Your browser doesn't support javascript.
loading
DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes.
Meunier, Léa; Hirsch, Théo Z; Caruso, Stefano; Imbeaud, Sandrine; Bayard, Quentin; Roehrig, Amélie; Couchy, Gabrielle; Nault, Jean-Charles; Llovet, Josep M; Blanc, Jean-Frédéric; Calderaro, Julien; Zucman-Rossi, Jessica; Letouzé, Eric.
Affiliation
  • Meunier L; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Hirsch TZ; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Caruso S; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Imbeaud S; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Bayard Q; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Roehrig A; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Couchy G; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Nault JC; Centre de Recherche des CordeliersSorbonne Université, INSERM, Université de Paris, Université Paris Nord, Functional Genomics of Solid Tumors Laboratory, Equipe Labellisée Ligue Contre le CancerParisFrance.
  • Llovet JM; Service d'HépatologieHôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance Publique-Hôpitaux de ParisBondyFrance.
  • Blanc JF; Unité de Formation et de Recherche Santé Médecine et Biologie HumaineUniversité Paris 13, Communauté d'Universités et Etablissements Sorbonne Paris CitéParisFrance.
  • Calderaro J; Mount Sinai Liver Cancer Program, Division of Liver DiseasesTisch Cancer Institute, Icahn School of Medicine at Mount SinaiNew YorkNY.
  • Zucman-Rossi J; Translational Research in Hepatic Oncology, Liver UnitIDIBAPS, Hospital ClinicUniversity of BarcelonaBarcelonaCataloniaSpain.
  • Letouzé E; Institució Catalana d'Estudis Avançats (ICREA)BarcelonaSpain.
Hepatology ; 74(2): 816-834, 2021 08.
Article in En | MEDLINE | ID: mdl-33713365
ABSTRACT
BACKGROUND AND

AIMS:

DNA methylation patterns are highly rearranged in HCCs. However, diverse sources of variation are intermingled in cancer methylomes, precluding the precise characterization of underlying molecular mechanisms. We developed a computational framework (methylation signature analysis with independent component analysis [MethICA]) leveraging independent component analysis to disentangle the diverse processes contributing to DNA methylation changes in tumors. APPROACH AND

RESULTS:

Applied to a collection of 738 HCCs, MethICA unraveled 13 stable methylation components preferentially active in specific chromatin states, sequence contexts, and replication timings. These included signatures of general processes associated with sex and age but also signatures related to specific driver events and molecular subgroups. Catenin beta 1 mutations were major modulators of methylation patterns in HCC, characterized by a targeted hypomethylation of transcription factor 7-bound enhancers in the vicinity of Wnt target genes as well as a widespread hypomethylation of late-replicated partially methylated domains. By contrast, demethylation of early replicated highly methylated domains was a signature of replication stress, leading to an extensive hypomethylator phenotype in cyclin-activated HCC. Inactivating mutations of the chromatin remodeler AT-rich interactive domain-containing protein 1A were associated with epigenetic silencing of differentiation-promoting transcriptional networks, also detectable in cirrhotic liver. Finally, a hypermethylation signature targeting polycomb-repressed chromatin domains was identified in the G1 molecular subgroup with progenitor features.

CONCLUSIONS:

This study elucidates the diversity of processes remodeling HCC methylomes and reveals the epigenetic and transcriptional impact of driver alterations.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Genetic Heterogeneity / DNA Methylation / Liver Neoplasms Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Hepatology Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Genetic Heterogeneity / DNA Methylation / Liver Neoplasms Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Hepatology Year: 2021 Type: Article